Concepedia

Geraldine O’Sullivan Coyne

GO

32

Publications

1.8K

Citations

20

H-Index

2007

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Frederick National Laboratory for Cancer Research

The University of Texas MD Anderson Cancer Center

Geraldine O’Sullivan Coyne is an author at National Cancer Institute specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2007–2025

32

Publications

32

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan et al. · The Lancet Oncology · 2017 · 292 citations · Full text

, , +6

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)

Shivaani Kummar, Geraldine O’Sullivan Coyne, T. Khanh et al. · Journal of Clinical Oncology · 2017 · 187 citations · Full text

, , +17

Curcumin induces apoptosis-independent death in oesophageal cancer cells

Geraldine O’Sullivan Coyne, G. C. O’Sullivan, Tracey R. O’Donovan et al. · British Journal of Cancer · 2009 · 154 citations · Full text

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

Arun Rajan, Christopher R. Heery, Anish Thomas et al. · Journal for ImmunoTherapy of Cancer · 2019 · 132 citations · Full text

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

Alice P. Chen, Elad Sharon, Geraldine O’Sullivan Coyne et al. · New England Journal of Medicine · 2023 · 124 citations · Full text

Rows per page

1–5 of 32